Diane Ling, MD

Title(s)Assistant Professor of Clinical Radiation Oncology
SchoolKeck School of Medicine of Usc
Address1450 Biggy Street
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Diane C. Ling is an Assistant Professor of Clinical Radiation Oncology at the Keck School of Medicine. She joined the faculty in August, 2020. Her clinical practice is split between USC+ Los Angeles County Medical Center and USC Norris Cancer Hospital.

    She grew up in the Bay Area and Sacramento, and graduated from the University of California, Berkeley with a bachelor’s degree in Molecular and Cell Biology. She earned her medical doctorate degree at the University of Pittsburgh School of Medicine, where she was inducted into the Alpha Omega Alpha Honor Medical Society. She completed her residency at the University of Pittsburgh Medical Center, Hillman Cancer Center in Pittsburgh, PA, where she was chief resident.

    Dr. Ling specializes in treating gastrointestinal and breast cancers. She has extensive experience with modern treatment techniques including intensity-modulated radiation therapy, volumetric-modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and motion management techniques. Her work has resulted in numerous publications, presentations at national meetings, and conference awards, including the Young Oncologist Essay Award as well as the James D. Cox Award of Scientific Merit from the American Radium Society.

    Languages Spoken: English, Mandarin

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. In Regard to Jagsi et al. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):1063-1064. Ling DC, Beriwal S. PMID: 35190049.
      View in: PubMed   Mentions:
    2. Definitive chemoradiation or radiation therapy alone for the management of vulvar cancer. Int J Gynecol Cancer. 2022 03; 32(3):332-337. Barry PN, Ling DC, Beriwal S. PMID: 35256420.
      View in: PubMed   Mentions:
    3. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):147-159. Grimm J, Vargo JA, Mavroidis P, Moiseenko V, Emami B, Jain S, Caudell JJ, Clump DA, Ling DC, Das S, Moros EG, Vinogradskiy Y, Xue J, Heron DE. PMID: 33583641.
      View in: PubMed   Mentions:
    4. Hypofractionated Prostate Radiation Therapy: Adoption and Dosimetric Adherence Through Clinical Pathways in an Integrated Oncology Network. JCO Oncol Pract. 2021 04; 17(4):e537-e547. Schad MD, Patel AK, Ling DC, Smith RP, Beriwal S. PMID: 33095692.
      View in: PubMed   Mentions:
    5. Ureteral stenosis after 3D MRI-based brachytherapy for cervical cancer - Have we identified all the risk factors? Radiother Oncol. 2021 02; 155:86-92. Rodríguez-López JL, Ling DC, Keller A, Kim H, Mojica-Márquez AE, Glaser SM, Beriwal S. PMID: 33065181.
      View in: PubMed   Mentions:
    6. Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care? Int J Radiat Oncol Biol Phys. 2020 10 01; 108(2):390-393. Ling DC, Vargo JA, Beriwal S. PMID: 32890517; PMCID: PMC7462831.
      View in: PubMed   Mentions:
    7. Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate? Gynecol Oncol. 2020 12; 159(3):657-662. Richman AH, Vargo JA, Ling DC, Sukumvanich P, Berger JL, Boisen MM, Edwards R, Taylor SE, Courtney-Brooks MB, Olawaiye A, Orr BC, Beriwal S. PMID: 32981696.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    8. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study. Gynecol Oncol. 2020 10; 159(1):23-29. Pifer PM, Bhargava R, Patel AK, Ling DC, Vargo JA, Orr BC, Sukumvanich P, Courtney-Brooks MB, Boisen MM, Berger JL, Taylor S, Olawaiye AB, Comerci JT, Lesnock JL, Edwards RP, Beriwal S. PMID: 32718729.
      View in: PubMed   Mentions:
    9. Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network-Can We Translate Results From Randomized Trials Into the Clinic? Pract Radiat Oncol. 2021 Jan-Feb; 11(1):e30-e35. Ling DC, Moppins BL, Champ CE, Gorantla VC, Beriwal S. PMID: 32615162.
      View in: PubMed   Mentions:
    10. Physician-Predicted Prognosis and Palliative Radiotherapy Treatment Utilization at the End of Life: An Audit of a Large Cancer Center Network. J Pain Symptom Manage. 2020 11; 60(5):898-905.e7. Mojica-Márquez AE, Rodríguez-López JL, Patel AK, Ling DC, Rajagopalan MS, Beriwal S. PMID: 32599149.
      View in: PubMed   Mentions:
    11. External validation of life expectancy prognostic models in patients evaluated for palliative radiotherapy at the end-of-life. Cancer Med. 2020 08; 9(16):5781-5787. Mojica-Márquez AE, Rodríguez-López JL, Patel AK, Ling DC, Rajagopalan MS, Beriwal S. PMID: 32592315; PMCID: PMC7433812.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status. Am J Clin Oncol. 2019 11; 42(11):837-844. Kim H, Vargo JA, Ling DC, Beriwal S, Smith KJ. PMID: 31644441.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy. Adv Radiat Oncol. 2020 Mar-Apr; 5(2):163-170. Ling DC, Iarrobino NA, Champ CE, Soran A, Beriwal S. PMID: 32280815; PMCID: PMC7136630.
      View in: PubMed   Mentions:
    14. Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and/or Paraortic Recurrences of Gynecologic Malignancies. Pract Radiat Oncol. 2019 Nov; 9(6):418-425. Ling DC, Vargo JA, Burton SA, Heron DE, Beriwal S. PMID: 31150869.
      View in: PubMed   Mentions:
    15. In Reply to Miranda Degrande and Hanna. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):221-222. Patel AK, Ling DC, Beriwal S. PMID: 30967229.
      View in: PubMed   Mentions:
    16. Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy? Int J Radiat Oncol Biol Phys. 2019 07 15; 104(4):869-876. Ling DC, Sutera PA, Iarrobino NA, Diego EJ, Soran A, Johnson RR, Bhargava R, Champ CE, Beriwal S. PMID: 30885777.
      View in: PubMed   Mentions:
    17. Long-Term Patient-Reported Rectal Bleeding and Bowel-Related Quality of Life After Cs-131 Prostate Brachytherapy. Int J Radiat Oncol Biol Phys. 2019 07 01; 104(3):622-630. Ling DC, Chen KS, Benoit RM, Beriwal S, Smith RP. PMID: 30853423.
      View in: PubMed   Mentions:
    18. Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer. Gynecol Oncol. 2019 03; 152(3):581-586. Ling DC, Vargo JA, Glaser SM, Kim H, Beriwal S. PMID: 30600093; PMCID: PMC7422921.
      View in: PubMed   Mentions:
    19. Lag Time Between Evidence and Guidelines: Can Clinical Pathways Bridge the Gap? J Oncol Pract. 2019 Mar; 15(3):e195-e201. Rodríguez-Lopéz JL, Ling DC, Heron DE, Beriwal S. PMID: 30526227.
      View in: PubMed   Mentions:
    20. Declining brachytherapy utilization for high-risk prostate cancer-Can clinical pathways reverse the trend? Brachytherapy. 2018 Nov - Dec; 17(6):895-898. Ling DC, Karukonda P, Smith RP, Heron DE, Beriwal S. PMID: 30217434.
      View in: PubMed   Mentions:
    21. Hypofractionated Whole-Breast Irradiation in Large-Breasted Women-Is There a Dosimetric Predictor for Acute Skin Toxicities? Int J Radiat Oncol Biol Phys. 2019 01 01; 103(1):71-77. Patel AK, Ling DC, Richman AH, Champ CE, Huq MS, Heron DE, Beriwal S. PMID: 30145393.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    22. Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose-Response for Late Toxicity. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):602-609. Ling DC, Flickinger JC, Burton SA, Heron DE, Quinn AE, Bejjani GK, Engh JA, Gerszten PC, Amankulor NM, Vargo JA. PMID: 29678526; PMCID: PMC7453968.
      View in: PubMed   Mentions:
    23. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):195-200. Gebhardt BJ, Vargo JA, Ling D, Jones B, Mohney M, Clump DA, Ohr JP, Ferris RL, Heron DE. PMID: 29398127; PMCID: PMC7425587.
      View in: PubMed   Mentions:
    24. Treatment of Early-Stage Hodgkin Lymphoma: Are We Just Shifting Morbidities? J Clin Oncol. 2017 08 20; 35(24):2849-2850. Vargo JA, Ling DC, Beriwal S. PMID: 28682691.
      View in: PubMed   Mentions:
    25. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol. 2016 10; 61:41-6. Ling DC, Chapman BV, Kim J, Choby GW, Kabolizadeh P, Clump DA, Ferris RL, Kim S, Beriwal S, Heron DE, Duvvuri U. PMID: 27688103; PMCID: PMC7717075.
      View in: PubMed   Mentions:
    26. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 07 01; 95(3):973-980. Ling DC, Vargo JA, Ferris RL, Ohr J, Clump DA, Yau WW, Duvvuri U, Kim S, Johnson JT, Bauman JE, Branstetter BF, Heron DE. PMID: 27302512.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    27. Underutilization of radiation therapy in early-stage marginal zone lymphoma negatively impacts overall survival. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):e97-e105. Ling DC, Vargo JA, Balasubramani GK, Beriwal S. PMID: 26852172.
      View in: PubMed   Mentions:
    Diane's Networks
    Concepts (139)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _